Princess Margaret Cancer Centre Innovation Accelerator Fund

The Princess Margaret Cancer Centre’s Innovation Acceleration Fund (IAF) has been established to overcome barriers to research translation.  Its objective is to accelerate research discoveries made by Princess Margaret Cancer Centre researchers to demonstrate commercial applicability to potential industry partners.

A maximum of $250,000 is available per proposal. Eligible researchers affiliated with the Princess Margaret Cancer Centre can learn more here or by contacting Dr. Bharti Ranavaya, IAF Investment Manager & Business Development and Commercialization Principal for Princess Margaret Cancer Centre at IAFinfo@tdc.uhnresearch.ca.